C1q and systemic lupus erythematosus

Immunobiology

Volumn 199, Issue 2, 1998, Pages 265-285

  Walport, Mark J ^a   Davies, Kevin A ^a   Botto, Marina ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HYPOCOMPLEMENTEMIA; KNOCKOUT MOUSE; MALE; MOLECULAR WEIGHT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY; VASCULITIS;

EID: 0031697215     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80032-6     Document Type: Article

References (93)

1. NISHINO, H., K. SHIBUYA, Y. NISHIDA, and M. MUSHIMOTO. 1981. Lupus erythematosuslike syndrome with selective complete deficiency of C1q. Ann. Intern. Med. 95: 322.
2. KOMATSU, A., M. KOMAZAWA, M. MURAKAMI, and Y. NAGAKI. 1982. A case of selective C1q-deficiency with SLE-like symptoms. J. Jap. Paediatr. Soc. 86: 23.
3. ORIHARA, T., K. TSUCHIYA, S. YAMASAKI, and T. FURUYA. 1987. Selective C1q deficiency in a patient with systemic lupus erythematosus. Br. J. Dermatol. 117: 247.
4. BERKEL, A.I., O. SANAL, R. THESEN, and M. LOOS. 1977. A case of selective C1q deficiency. The Turkish Journal of Pediatrics. 19: 101.
5. BERKEL, A.I., M. LOOS, O. SANAL, G. MAUFF, Y. GUNGEN, U. URS, F. ERSOY, and O. YEGIS. 1979. Clinical and immunological studies in a case of selective complete C1q deficiency. Clin. Exp. Immunol. 38: 52.
6. LOOS, M., A.B. LAURELL, A.G. SJOHOLM, U. MARTENSSON, and A.I. BERKEL. 1980. Immunochemical and functional analysis of a complete C1q deficiency in man: evidence that C1r and C1s are in the native form and that they reassociate with purified C1q to form macromolecular C1. J. Immunol. 124: 59.
7. PETRY, F., A.I. BERKEL and M. LOOS. 1997. Multiple identification of a particular type of hereditary C1q deficiency in a Turkish population: review of the cases and additional genetic and functional studies. Hum. Genet. 100: 51.
8. MAMPASO, F., J. ECIJA, L. FOGUE, I. MONEO, N. GALLEGO, and F. LEYVA COBIAN. 1981. Familial C1q deficiency in 3 siblings with glomerulonephritis and Rothmund-Thomson syndrome. Nephron. 28: 179.
9. NAGAKI, K., A. KAMINAKA, and A. KOMATSU. 1982. A selective C1q deficiency. Allergy 31: 530.
10. UENAKA, A., T. AKIMOTO, T. AOKI I. TSUYUGUCHI, and K. NAGAKI. 1982. A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE). Clin. Exp. Immunol. 48: 353.
11. MINTA, J.O., C.J. WINKLER, W.D. BIGGAR, and M. GREENBERG. 1982. A selective and complete absence of C1q in a patient with vasculitis and nephritis. Clin. Immunol. Immunopathol. 22: 225.
12. MIKUSKA, A.M., Z. STEFANOVIC, V. MILETIC, V-A. OXELIUS, and A.G. SJOHOLM. 1983. Sytemic lupus erythematosus-like disease in two siblings with complete C1q deficiency. Period Biol. 85: 271.
13. SLINGSBY, J.H., P. NORSWORTHY, G. PEARCE, A.K. VAISHNAW, H. ISSLER, B.J. MORLEY, and M.J. WALPORT. 1996. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum. 39: 663.
14. STEINSSON, K., R.H. MCLEAN, M. MERROW, N.F. ROTHFIELD, and A. WEINSTEIN. 1983. Selective complete C1q deficiency associated with systemic lupus erythematosus. J. Rheumatol. 10: 590.
15. BERKEL, A.I., M. LOOS, O. SANAL, F. ERSOY, and O. YEGIN. 1981. Selective complete C1q deficiency: report of two new cases. Immunol. Lett. 2: 263
16. BERKEL, A.I. 1993. Studies of immune response in a patient with selective complete C1q deficiency. Turk. J. Paedatr. 35: 221.
17. TOTH, J., Z. STARSIA, M. BUC, and J. STEFANOVIC. 1989. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency. Immunobiology 180: 47.
18. PETRY, F., D.T. LE, M. KIRSCHFINK, and M. LOOS. 1995. Non-sense and missense mutations in the structural genes of complement component C1q A and C chains are linked with two different types of complete selective C1q deficiencies. J. Immunol. 155: 4734.
19. BOWNESS, P., K.A. DAVIES, P.J. NORSWORTHY, P. ATHANASSIOU, J. TAYLOR WIEDEMAN L.K. BORYSIEWICZ, P.A. MEYER, and M.J. WALPORT. 1994. Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 87: 455.
20. BERKEL, A.I., F. PETRY, O. SANAL, K. TINAZTEPE, F. ERSOY, A. BAKKALOGLU, and M. LOOS. 1997. Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency. Eur. J. Pediatr. 156: 113.
21. TOPALOGLU, R., A. BAKKALOGLU, J.H. SLINGSBY, M.J. MIHATSCH, M. PASCUAL, P. NORSWORTHY, B.J. MORLEY, U. SAATCI, J.A. SCHIFFERLI, and M.J. WALPORT. 1996. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 50: 635.
22. THOMPSON, R.A., M. HAENEY, K.B.M. REID, J.G. DAVIES, R.H.R. WHITE, and A.H. CAMERON. 1980. A genetic defect of the C1q subcomponent of complement associated with childhook (immune complex) nephritis. N. Engl. J. Med. 303: 22.
23. REID, K.B.M. and R.A. THOMPSON. 1983. Characterization of a non-functional torm of C1q found in patients with a genetically linked deficiency of C1q activity. Mol. Immunol. 20: 1117.
24. MCADAM, R.A., D. GOUNDI, and K.B.M. REID. 1988. A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual. Immunogenetics 27: 259.
25. MEYER, O., G. HAUPTMANN, G. TAPPEINER, H.D. OCHS, and F. MASCART-LEMONE. 1985. Genetic deficiency of C4, C2 or C1q and lupus syndromes Association with anti-Ro (SS-A) antibodies. Clin. Exp. Immunol. 62: 678.
26. CHAPUIS, R.M., G. HAUPTMANN, E. GROSSHANS, and H. ISLIKER. 1982. Structural and functional studies in C1q deficiency. J. Immunol. 129: 1509.
27. PETRY, F., G. HAUPTMANN, J. GOETZ, E. GROSSHANS, and M. LOOS. 1997. Molecular basis of a new type of C1q deficiency associated with a non-functional low molecular weight (LMW) C1q - parallels and differences to other known genetic C1q-defects. Immunopharmacology 38: 189.
28. HANNEMA, A.J., J.C. KLUIN NELEMANS, C.E. HACK, A.J. EERENBERG BELMER, C. MALLEE, and H.P. VAN HELDEN. 1984. SLE like syndrome and functional deficiency of C1q in members of a large family. Clin. Exp. Immunol. 55: 106.
29. KIRSCHFINK, M., F. PETRY, K. KIRWADKAR, R. WIGAND, J.P. KALTWASSER, and M. LOOS. 1993. Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 94: 267.
30. SUWAIRI, W., S. BAHABRI, D. BEVING, J. WISNIESKI, and M. WARMAN. 1997. Dysfunctional and antigenically abnormal C1q resulting from a point mutation in Codon 6 of the C-chain. Arthritis Rheum. 40(119): S308.(Abstract)
31. WARA, D.W., E.O. REITER, N.E. DOYLE, H. GEWURZ, and A.J. AMMAN. 1975. Persistent C1q deficiency in a patient with a systemic lupus erythematosus-like syndrome. J. Pediatr. 86: 743.
32. MORGAN, B.P. and M.J. WALPORT. 1991. Complement deficiency and disease. Immunol. Today 12: 301.
33. BOTTO, M., and M.J. WALPORT. 1993. Hereditary deficiency of C3 in animals and humans. Intern. Rev. Immunol. 10: 37.
34. NILSSON, U.R., B. NILSSON, K.E. STORM, G. SJOLIN FORSBERG, and R. HALLGREN. 1992. Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis. Arthritis Rheum. 35: 580.
35. PELEG, D., H. HARIT-BUSTAN, Y. KATZ, S. PELLER, M. SCHLESINGER, and S. SCHONFELD. 1992. Inherited C3 deficiency and meningococcal disease in a teenager. Pediatr. Infect. Dis. J. 11: 401.
36. FUKUMORI, Y., K. YOSHIMURA, S. OHNOKI, H. YAMAGUCHI, Y. AKAGAKI, and S. INAI. 1989. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int. Immunol. 1: 85.
37. KAWAI, T., K. KATOH, M. NARITA, K. TANI, and T. OKUBO. 1989. Deficiency of the 9th component of complement (C9) in a patient with systemic lupus erythematosus. J. Rheumatol. 16: 542.
38. KOHLER, P.F. and H.J. MULLER EBERHARD. 1972. Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. J. Clin. Invest. 51: 868.
39. DE BRACCO, M.M. and J.A. MANNI. 1974. Serum levels of C1q, C1r and C1s in normal and pathologic sera. Arthritis Rheum. 17: 121.
40. STURFELT, G., A.G. SJOHOLM, and B. SVENSSON. 1983. Complement components, C1 activation and disease activity in SLE. Int. Arch. Allergy Appl. Immunol. 70: 12.
41. SWAAK, A.J., L.A. AARDEN, L.W. STATIUS VAN EPS, and T.E. FELTKAMP. 1979. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 22: 226.
42. HOEKZEMA, R., A.J. HANNEMA, T.J. SWAAK, J. PAARDEKOOPER, and C.E. HACK. 1985. Low molecular weight C1q in systemic lupus erythematosus. J. Immunol. 135: 265.
43. SIEGERT, C., M. DAHA, M.L. WESTEDT, E. VAN DER VOORT, and F. BREEDFELD. 1991. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18: 230.
44. MENZEL, J.E., O. SCHERAK, G. KOLARZ, F. GAMERITH, and U. YOUNGCHAIYUD. 1991. A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid phase C1q. J. Immunol. Methods 138: 165.
45. WISNIESKI, J.J. and G.B. NAFF. 1989. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum. 32: 1119.
46. COOK, A.D., M.J. ROWLEY, B.D. WINES, and I.R. MACKAY. 1994. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis. J. Autoimmun. 7: 369.
47. COREMANS, I.E., P.E. SPRONK, H. BOOTSMA, M.R. DAHA, E.A. VAN DER FOORT, L. KATER, F.C. BREEDFELD, and C.G. KALLENBERG. 1995. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26: 595.
48. FREMEAUX BACCHI, V., L. WEISS, C. DDEMOUCHY, J. BLOUIN, and M.D. KAZATCHKINE. 1996. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5: 216.
49. MARCHANG, P., C.F. EBENBICHLER, and M.P. DIERICH. 1994. HIV and complement: role of the complement system in HIV infection. Int. Arch. Allergy Immunol. 103: 113.
50. MONTEFIORI, D.C., K. STEWART, J.M. AHEARN, and J. ZHOU. 1993. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J. Virol. 67: 2699.
51. HEIDELBERGER, M. 1941. Quantitative chemical studies on complement or alexin. I A method. J. Exp. Med. 73: 691.
52. WALPORT, M.J. and K.A. DAVIES. 1996. Complement and immune complexes. Res. Immunol. 147: 103.
53. SCHIFFERLI, J.A. and D.K. PETERS. 1983. Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet 957.
54. WALPORT, M.J., K.A. DAVIES, B.J. MORLEY, and M. BOTTO. 1997. Complement deficiency and autoimmunity. Ann. NY. Acad. Sci. 815: 267.
55. LOBATTO, S., M.R. DAHA, F.C. BREEDVELD, E.K. PAUWELS, J.H. EVERS SCHOUTEN, A.A. VOETMAN, A. CATS, and L.A. VAN ES. 1988. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 72: 55.
56. SCHIFFERLI, J.A., Y.C. NG, J. ESTREICHER, and M.J. WALPORT. 1988. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J. Immunol. 140: 899.
57. DAVIES, K.A., K. ERLENDSSON, H.L.C. BEYNON, A.M. PETERS, K. STEINSSON, H. VALDIMARSSON, and M.J. WALPORT. 1993. Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151: 3866.
58. PETERS, A.M., S.H. SAVERYMUTTU, R.N. BELL, and J.P. LAVENDER. 1985. Quantification of the distribution of the marginating granulocyte pool in man. Scand. J. Haematol. 34: 111.
59. FRANK, M.M., T.J. LAWLEY, M.I. HAMBURGER, and E.J. BROWN. 1983. Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann. Intern. Med. 98: 206.
60. SAVILL, J.S., I. DRANSFIELD, N HOGG, and C. HASLETT. 1990. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343: 170.
61. FADOK, V.A., D.R. VOELKER, P.A. CAMPBELL, J.J. COHEN, D.L. BRATTON, and P.M. HENSON. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207.
62. KORB, L.C. and J.M. AHEARN. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158: 4525.
63. CASCIOLA ROSEN, L, G. ANHALT, and A. ROSEN. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317
64. CASCIOLA ROSEN, L., A. ROSEN, M. PETRI, and M. SCHLISSEL. 1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93: 1624.
65. ROSEN, A., L. CASCIOLA ROSEN, and J. AHEARN. 1995. Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med. 181: 1557.
66. JUNE, C.H., C.E. CONTRERAS, L.H. PERRIN, and P. LAMBERT. 1979. Improved detection of immune complexes in human and mouse serum using a microassay adaptation of the C1q binding test. J. Immunol. Methods. 31: 23.
67. ABRASS, C.K., K.M. NIES, J.S. LOUIE, W.A. BORDER, and R.J. GLASSOCK. 1980. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 23(3): 273.
68. MCCARTHY, D., D.H. GODDARD, E.J. HOLBOROW, A.C. HORSFALL, P.A. MUMFORD, and R.N. MAINI. 1981. The effect of IgG aggregate size and concentration on reactivity in immune complex assays. J. Immunol. Methods 47: 349.
69. MANNIK, M. 1980. Physiochemical and functional relationships of immune complexes. J. Invest. Dermatol. 74: 333.
70. AGNELLO, V., D. KOFFLER, J.W. EISENBERG, R.J. WINCHESTER, and H.G. KUNKEL. 1971. C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterisation of high and low molecular weight types. J. Exp. Med. 134(3): 228.
71. ROBINSON, M.F., L.J. ROBERTS, J.V. JONES, and E.J. LEWIS. 1979. Circulating immune complexes in patients with lupus and membranous glomerulonephritis. Clin. Immunol. Immunopathol. 14: 348.
72. HURST, N.P., G. NUKI, and T. WALLINGTON. 1984. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 55: 303.
73. UWATOKO, S., S. AOTSUKA, M. OKAWA, Y. EGUSA, R. YOKOHARI, C. AIZAWA, and K. SUZUKI. 1987. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 69: 98.
74. ANTES, U., H.P. HEINZ, and M. LOOS. 1988. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 31: 457.
75. GOLAN, M.D., R. BURGER, and M. LOOS. 1982. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J. Immunol. 129: 445.
76. HOEKZEMA, R., M. MARTENS, M.C. BROUWER, and C.E. HACK. 1988. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the «arms» of C1q. Mol. Immunol. 25: 485.
77. CLYNES, R., C. DUMITRU, and J.V. RAVETCH. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052.
78. DUITS, A.J., H. BOOTSMA, R.H. DERKSEN, P.E. SPRONK, L. KATER, G.G. KALLENBERG, P.J. CAPEL, N.A. WESTERDAAL, G.T. SPIERENBURG, F.H. GMELIG MEYLING, and et al.. 1995. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis. Rheum. 38: 1832.
79. SANDERS, L.A., R.G. FELDMAN, M.M. VOORHORST OGINK, M. DE HAAS, G.T. RIJKERS, P.J. CAPEL, B.J. ZEGERS, and J.G. VAN DE WINKEL. 1995. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 63: 73.
80. REILLY, A.F., C.F. NORRIS, S. SURREY, F.J. BRUCHAK, E.F. RAPPAPORT, E. SCHEARTZ and S.E. MCKENZIE. 1994. Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism. Clin. Diagn. Lab. Immunol. 1: 640.
81. KIMBERLEY, R.P., J.E. SALMON, and J.C. EDBERG. 1995. Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum. 38: 306.
82. SALMON, J.E., S. MILLARD, L.A. SCHACHTER, F.C. ARNETT, E.M. GINZLER, M.F. GOURLEY, R. RAMSEY GOLDMAN, M.G. PETERSON, and R.P. KIMBERLY. 1996. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97: 1348.
83. HASELEY, L.A., J.J. WISNIESKI, M.R. DENBURG, A.R. MICHAEL-GROSSMAN, E.M. GINZLER, M.F. GORLEY, J.H. HOFFMAN, R.P. KIMBERLY, and J.E. SALMON. 1997. Antibodies to C1q in SLE: Characteristics in relation to Fc gamma RII alleles. Kidney Int. 52: 1375.
84. MANNIK, M. and M.H. WENER. 1997. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 40: 1504.
85. RORDORF ADAM, C., D. SERBAN, A. PATAKI, and M. GRUNINGER. 1985. Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/ lpr mice. Clin. Exp. Immunol. 61: 509.
86. TRINDER, P.K., M.J. MAEURER, H.U. SCHORLEMMER, and M. LOOS. 1995. Autoreactivity to mouse C1q in a murine model of SLE. Rheumatol. Int. 15: 117.
87. HOGARTH, M.B., P.J. NORSWORTHY, P.J. ALLEN, P.K. TRINDER, M. LOOS, B.J. MORLEY, M.J. WALPORT and K.A. DAVIES. 1996. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice. Clin. Exp. Immunol. 104: 241.
88. WESSELS, M.R., P. BUTKO, M. MA, H.B. WARREN, A.L. LAGE, and M.C. CARROLL. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92: 11490.
89. FISCHER, M.B., M. MA, S. GOERG, X. ZHOU, J. XIA, O. FINCO, S. HAN, G. KELSOE, R.G. HOWARD, T.L. ROTHSTEIN, E. KREMMER, F.S. ROSEN, and M.C. CARROLL. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157: 549.
90. MOLINA, H., V.M. HOLERS, B. LI, Y. FUNG, S. MARIATHASAN, J. GOELLNER, J. STRAUSS SCHOENBERGER, R.W. KARR, and D.D. CHAPLIN. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357.
91. AHEARN, J.M., M.B. FISHER, D. CROIX, S. GOERG, M. MA, J. XIA, X. ZHOU, R.G. HOWARD, T.L. ROTHSTEIN, and M.C. CARROLL. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cells response to T-dependent antigen. Immunity 4: 251
92. MATSUMOTO, M., W. FUKUDA, A. CIRCOLO, J. GOELLNER, J. STRAUSS SCHOENBERGER, X. WANG, S. FUJITA, T. HIDVEGI, D.D. CHAPLIN, and H.R. COLTEN. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94: 8720.
93. BAKER, A.J., A. MOONEY, J. HUGHES, D. LOMBARDI, R.J. JOHNSON, and J. SAVILL. 1994. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94: 2105.